Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	(26) Subsequent Events Termination of Volumetric Milestones Related to Potential Earnout Payments Following the acquisition of Volumetric in 2021, the Company could have been required to pay up to $355,000 of acquisition-related earnout payments to the former owners of Volumetric if the Company were to achieve seven non-financial, science-based milestones prior to either December 31, 2030 or December 31, 2035 (refer to Note 3 and Note 17). After losing funding for research on kidneys and livers from the Company’s key strategic partner for the related R&D efforts, on February 24, 2024 the Company notified the former owners of Volumetric that it was terminating the four milestones relating to kidney and liver research because achievement was no longer financially viable. As a result of the termination of these four milestones, the Company's maximum liability for acquisition-related earnout payments was reduced to $175,000, which would be payable if each of the three remaining non-financial, science-based milestones were achieved within the timeframes set forth in the Volumetric acquisition agreement. On March 29, 2024, the former owners of Volumetric notified the Company that they were initiating dispute resolution under the provisions of the Volumetric acquisition agreement in an effort to recover the $355,000. The parties did not reach a resolution during the 30-day negotiation period following the notice and entered into non-binding mediation in accordance with the terms of the Volumetric acquisition agreement. Further, on April 29, 2024, two of the former Volumetric shareholders terminated their employment with the Company. The two former shareholders claim that their terminations were for good reason, which would preserve their rights to earn milestone payments under the merger agreement. The Company vigorously denies their claim that the termination was for good reason and contends that the former shareholders of Volumetric are now no longer eligible to achieve any of the remaining three non-financial, science-based milestones or earn any of the related $175,000 of milestone payments. On July 8, 2024, the Company proposed a settlement of $1,500 with the former shareholders and key employees of Volumetric during mediation. The proposed settlement was accrued as expense during the three months ended March 31, 2024. On July 24, 2024, the former shareholders and key employees rejected the offer and proposed a counteroffer that the Company does not intend to accept. As of August 13, 2024, the mediation process between the parties remains ongoing. Payment of Portion of Government Settlement Penalty During February 2024, the Company paid $3,500 to DDTC in satisfaction of the second installment of its settlement penalty totaling $10,000 related to export controls and International Traffic in Arms Regulations. Refer to Note 23 for additional details regarding this government settlement. Repurchases of Debt On March 8, 2024, the Company repurchased $110,492 aggregate principal amount of its outstanding Notes from certain holders for an aggregate cash repurchase price of $87,218 including transaction expenses. Refer to Note 13 for additional details regarding debt extinguishment. Convertible Notes Compliance The Company’s failure to file this 2023 Form 10-K and provide it to the trustee by April 1, 2024 represents a default under the terms of the Indenture. In addition, the Company's failure to file its Form 10-Q for the three months ended March 31, 2024 and provide it to the trustee by May 30, 2024 represented an incremental default under the terms of the Indenture. These defaults will not become an event of default under the terms of the Indenture if the Company files this Form 10-K and its Form 10-Q for the three months ended March 31, 2024 prior to the end of the cure period provided for by the Indenture, which cure period has not yet been initiated by the trustee or holders of the Notes. The Company has not incurred any special interest as a result of this default, nor have the Notes become subject to any other actions by the holders. Sale of Oqton Dental During May 2024, the Company completed the sale of the portion of the Oqton MOS business that was focused on the dental market ("Oqton Dental") in exchange for a de minimis amount of cash, resulting in the transfer of a limited portion of Oqton MOS's personnel and a de minimis amount of fixed assets. Incremental Investment in NAMI In May 2024, the Company made an incremental investment of $2,450 in NAMI, the Company's joint venture with Dussur. Refer to Note 10 for additional details regarding this equity method investment.